Standard systemic therapy
Phase 3
Standard systemic therapy is one of 3 therapeutic programs targeting Gastric Cancer Peritoneal Metastases. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
2
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
2 competitors in Gastric Cancer Peritoneal Metastases
#DrugCompanyPhaseTrials
1Standard Chemotherapy
RochePhase 3
Intraperitoneal Paclitaxel
EECOG-ACRIN Cancer Research Group
Phase 3
Standard systemic therapy
MMagnus Nilsson
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for Standard systemic therapy. EMBL-EBI & Wellcome Sanger Institute.
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Phase 3[1]
- Company
- MMagnus Nilsson